Future Market Insights foresees significant growth opportunities in hydrocephalus shunt market, considering the new-age development of smart shunt technology, while delivering advance diagnosis of cerebrospinal fluid (CSF), control, and communication, on the basis of sensors, telemetry, and feedback controls. Increasing focus on developing such smart shunt technology, is anticipated to prove favorable for the hydrocephalus shunt market—showcasing an otherwise sluggish landscape through the forecast period of 2018-2028, as per FMI’s analysis.
The research intelligence report offers a deep-dive view of the global hydrocephalus shunt market—predicted to expand at a rather sluggish rate of 2.3 percent, reaching a valuation of US$ 498.6 Mn in 2020.
“Stringent regulatory policies is a key factor severely impacting the growth of hydrocephalus shunt market. In addition, mechanical risks including leaks, migration, obstruction, and discontinuity and biological complications including infection, abscess, pseudocyst, heamotoma, and peritonitis associated with shunt implants, is also a key factor contributing to the market’s slow-moving growth. Other contributing factors could include high surgery costs and shortage of trained neurologist—specifically reported in countries like Australia, Canada, Ireland, U.K, and New”, explains a senior analyst from the Healthcare domain. The analyst further explains that shunt blockage and malfunction are two common complication associated with stunt implants—blockages occurring in nearly 31 percent patients. Moreover, such risks and complications often result in a number of hydrocephalus shunt revision surgeries, further creating a notable demand for hydrocephalus shunt.
Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-7756
FMI offers key insights on the global hydrocephalus shunt market
- Hydrocephalus valves segment is expected to hold a massive value share of nearly 85 percent.
- Within the Hydrocephalus valves type, adjustable pressure valves is likely to witness maximum adoption in hydrocephalus shunt surgeries.
- Highest growth potential exists in North America, with an attractiveness index of 2.6 during the forecast period. Such adoption trend is expected to be followed in Western Europe—the second most lucrative market, showcasing interesting profit possibilities.
- By age group, pediatrics and infants segment will report maximum adoption of hydrocephalus shunt.
- Ventriculoperitoneal will remain the most preferred procedure, pushing maximum revenue in the global hydrocephalus shunt.
Key Market Influencers: Technological Advancements and Awareness Campaigns for Hydrocephalus
Considering the complexity of hydrocephalus shunting along with adjustments of cerebrospinal fluid draining, manufacturers of hydrocephalus shunts are increasingly introducing programmable and anti-siphon shunt valves—aimed at regulating drainage pressure and flow. The new technologies are indicated to eliminate the need for surgery revisions as a result of complications. The cerebrospinal fluid management technologies are likely to witness increased adoption in the coming years considering its utility in reducing siphon effect over cerebrospinal fluid drainage. Programmable pressure valves are gaining prominence versus fix pressure valves owing to its external features using specialized magnetic devices that helps in modifying opening pressure of valves.
For More Information On This Report, Please Visit @ https://www.futuremarketinsights.com/checkout/7756
Additionally, demand for hydrocephalus shunts is slated to increase given the increasing number of government and private initiatives to spread awareness vis-à-vis hydrocephalus. Hydrocephalus Association, for instance, and its focus to conduct more hydrocephalus awareness campaigns and programs, with increased investments in research initiatives targeted at improving cure and treatment avenues for Hydrocephalus. Through its campaign ‘Roadmap to a Cure’, the organization, by 2020 is expected to invest US$20 and drive more research and support associated with hydrocephalus.
In the highly consolidated hydrocephalus shunt market, product and pricing power lies in the hand of top three players—reigning over nearly 84 percent of the total revenue share in the global hydrocephalus shunt market. Contributing nearly US$ 389 Million, the top three players include Medtronic Plc., Integra LifeSciences Corporation, and B. Braun Melsungen AG. Key forward market strategies include- viz. Efforts to gain regulatory approvals, geographic expansions in emerging economies, production capacity expansion, increased investments in R&D, and acquisitions to solidify global position in neurosurgery and regenerative technologies. Strategic collaborations in the form of mergers and acquisitions, is expected to bring significant growth opportunities for the three leading players, predicts FMI in its hydrocephalus shunt market report. For more insights on the competitive landscape of the hydrocephalus shunt market or any other additional queries, speak to our expert healthcare analysts, available at firstname.lastname@example.org
Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-7756
Additional Questions Answered
Some of the additional questions addressed in this report on the hydrocephalus shunt market-
- What is the revenue potential of the hydrocephalus shunt market across regions of North America and Europe?
- Who are the key competitors and their product portfolio and strategy in hydrocephalus shunt market?
- What are major challenges influencing the growth of hydrocephalus shunt market?
- How intervention from regulatory authority is shaping the hydrocephalus shunt market growth?
The hydrocephalus shunt market has been estimated based on epidemiology based model and number of procedures. The market was first calculated based on hydrocephalus epidemiology in different region/countries. The hydrocephalus shunt procedure volume was estimated based on the number of primary shunt implant and surgical revision procedure performed annually in top 20 countries globally. Other qualitative factors analyzed launch of new hydrocephalus valves and catheters, adoption of different technology based valves and catheters, regulatory policies related to hydrocephalus shunt. This information is further validated with rigorous primary research (including in-person interactions, interviews, surveys and viewpoints of seasoned analysts) and secondary research (including authentic trade journals, verified paid sources and resourceful databases). The research study on hydrocephalus shunt market also includes top trends and macro as well as microeconomic factors shaping the hydrocephalus shunt market. With this approach, the report on hydrocephalus shunt market anticipates the industry attractiveness of every major segment in hydrocephalus shunt over the forecast period.
About Us – Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
Future Market Insights
616 Corporate Way,
New York 10989,